IFNα, which suppresses EP4 expression and antagonizes PGE2-driven immune suppression [106], has demonstrated the ability to promote anti-tumor immunity in various bladder cancer models [123,124]. The gene discussed is IFNA1; the disease is urinary bladder cancer.